IGF1R signaling in Ewing Sarcoma is shaped by clathrin-/caveolin-dependent endocytosis

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Martins, Ana Sofia ^a   Ordóñez, José Luis ^a   Amaral, Ana Teresa ^a   Prins, Frans ^b   Floris, Giuseppe ^c   Debiec Rychter, Maria ^c   Hogendoorn, Pancras C W ^b   de Alava, Enrique ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AEW 541; CAVEOLIN; CAVEOLIN 1; CHLORPROMAZINE; CLATHRIN; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; NVP AEW 541; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; PROTEIN KINASE INHIBITOR; PROTEOME;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; ENDOCYTOSIS; ENDOSOME; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EWING SARCOMA; HUMAN; HUMAN CELL; INTERNALIZATION; LIGAND BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; CONFOCAL MICROSCOPY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

APOPTOSIS; CAVEOLIN 1; CELL LINE, TUMOR; CELL PROLIFERATION; CLATHRIN; ENDOCYTOSIS; HUMANS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEOME; RECEPTOR, IGF TYPE 1; SARCOMA, EWING'S; SIGNAL TRANSDUCTION;

EID: 79956143961     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019846     Document Type: Article

References (37)

1. Di Fiore PP, De Camilli P, (2001) Endocytosis and signaling. an inseparable partnership. Cell 106: 1-4.
2. Wang Y, Pennock SD, Chen X, Kazlauskas A, Wang Z, (2004) Platelet-derived growth factor receptor-mediated signal transduction from endosomes. J Biol Chem 279: 8038-8046.
3. Ceresa BP, Schmid SL, (2000) Regulation of signal transduction by endocytosis. Curr Opin Cell Biol 12: 204-210.
4. Navarro A, Anand-Apte B, Parat MO, (2004) A role for caveolae in cell migration. Faseb J 18: 1801-1811.
5. Minshall RD, Sessa WC, Stan RV, Anderson RG, Malik AB, (2003) Caveolin regulation of endothelial function. Am J Physiol Lung Cell Mol Physiol 285: L1179-1183.
6. Lin FT, Krueger KM, Kendall HE, Daaka Y, Fredericks ZL, et al. (1997) Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1. J Biol Chem 272: 31051-31057.
7. Wolfe BL, Trejo J, (2007) Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis. Traffic 8: 462-470.
8. Carelli S, Di Giulio AM, Paratore S, Bosari S, Gorio A, (2006) Degradation of insulin-like growth factor-I receptor occurs via ubiquitin-proteasome pathway in human lung cancer cells. J Cell Physiol 208: 354-362.
9. Sehat B, Andersson S, Girnita L, Larsson O, (2008) Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis. Cancer Res 68: 5669-5677.
10. Romanelli RJ, LeBeau AP, Fulmer CG, Lazzarino DA, Hochberg A, et al. (2007) Insulin-like growth factor type-I receptor internalization and recycling mediate the sustained phosphorylation of Akt. J Biol Chem 282: 22513-22524.
11. Martins AS, Mackintosh C, Martin DH, Campos M, Hernandez T, et al. (2006) Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor. Clin Cancer Res 12: 3532-3540.
12. Martins AS, Ordonez JL, Garcia-Sanchez A, Herrero D, Sevillano V, et al. (2008) A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study. Cancer Res 68: 6260-6270.
13. Parpal S, Karlsson M, Thorn H, Stralfors P, (2001) Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control. J Biol Chem 276: 9670-9678.
14. Wang LH, Rothberg KG, Anderson RG, (1993) Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 123: 1107-1117.
15. Cox ME, Gleave ME, Zakikhani M, Bell RH, Piura E, et al. (2009) Insulin receptor expression by human prostate cancers. Prostate 69: 33-40.
16. Jin Q, Esteva FJ, (2008) Cross-talk between the ErbB/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer. J Mammary Gland Biol Neoplasia 13: 485-498.
17. Dong A, Kong M, Ma Z, Qian J, Cheng H, et al. (2008) Knockdown of insulin-like growth factor 1 receptor enhances chemosensitivity to cisplatin in human lung adenocarcinoma A549 cells. Acta Biochim Biophys Sin (Shanghai) 40: 497-504.
18. Ma Z, Dong A, Kong M, Qian J, (2007) Silencing of the type 1 insulin-like growth factor receptor increases the sensitivity to apoptosis and inhibits invasion in human lung adenocarcinoma A549 cells. Cell Mol Biol Lett 12: 556-572.
19. Yang JL, Crowe PJ, (2007) Targeted therapies in adult soft tissue sarcomas. J Surg Oncol 95: 183-184.
20. Furukawa M, Raffeld M, Mateo C, Sakamoto A, Moody TW, et al. (2005) Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases. Clin Cancer Res 11: 3233-3242.
21. Strammiello R, Benini S, Manara MC, Perdichizzi S, Serra M, et al. (2003) Impact of IGF-I/IGF-IR circuit on the angiogenetic properties of Ewing's sarcoma cells. Horm Metab Res 35: 675-684.
22. Weroha SJ, Haluska P, (2008) IGF-1 receptor inhibitors in clinical trials--early lessons. J Mammary Gland Biol Neoplasia 13: 471-483.
23. Huang F, Greer A, Hurlburt W, Han X, Hafezi R, et al. (2009) The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitors. Cancer Res 69: 161-170.
24. Yuen JS, Macaulay VM, (2008) Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer. Expert Opin Ther Targets 12: 589-603.
25. Chuang LM, Myers MG Jr, Seidner GA, Birnbaum MJ, White MF, et al. (1993) Insulin receptor substrate 1 mediates insulin and insulin-like growth factor I-stimulated maturation of Xenopus oocytes. Proc Natl Acad Sci U S A 90: 5172-5175.
26. Myers MG Jr, Sun XJ, Cheatham B, Jachna BR, Glasheen EM, et al. (1993) IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinology 132: 1421-1430.
27. Giorgetti S, Pelicci PG, Pelicci G, Van Obberghen E, (1994) Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor. Eur J Biochem 223: 195-202.
28. van der Ven LT, Gloudemans T, Roholl PJ, van Buul-Offers SC, Bladergroen BA, et al. (1994) Growth advantage of human leiomyoma cells compared to normal smooth-muscle cells due to enhanced sensitivity toward insulin-like growth factor I. Int J Cancer 59: 427-434.
29. Hsu D, Knudson PE, Zapf A, Rolband GC, Olefsky JM, (1994) NPXY motif in the insulin-like growth factor-I receptor is required for efficient ligand-mediated receptor internalization and biological signaling. Endocrinology 134: 744-750.
30. Furlanetto RW, (1988) Receptor-mediated endocytosis and lysosomal processing of insulin-like growth factor I by mitogenically responsive cells. Endocrinology 122: 2044-2053.
31. Carpentier JL, (1994) Insulin receptor internalization: molecular mechanisms and physiopathological implications. Diabetologia 37 (Suppl 2): S117-124.
32. Chen J, Capozza F, Wu A, Deangelis T, Sun H, et al. (2008) Regulation of insulin receptor substrate-1 expression levels by caveolin-1. J Cell Physiol 217: 281-289.
33. Tirado OM, Mateo-Lozano S, Villar J, Dettin LE, Llort A, et al. (2006) Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells. Cancer Res 66: 9937-9947.
34. Toretsky JA, Kalebic T, Blakesley V, LeRoith D, Helman LJ, (1997) The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts. J Biol Chem 272: 30822-30827.
35. Podar K, Tai YT, Cole CE, Hideshima T, Sattler M, et al. (2003) Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells. J Biol Chem 278: 5794-5801.
36. Chow JC, Condorelli G, Smith RJ, (1998) Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway. J Biol Chem 273: 4672-4680.
37. Ottaviano L, Schaefer KL, Gajewski M, Huckenbeck W, Baldus S, et al. (2010) Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort. Genes Chromosomes Cancer 49: 40-51.